[Changes of antithrombin III, alpha2-macroglobulin, alpha1-antitrypsin, C1-inhibitor and alpha2-plasmin inhibitor in arteriosclerotic diseases and diabetes mellitus (author's transl)]
- PMID: 81330
[Changes of antithrombin III, alpha2-macroglobulin, alpha1-antitrypsin, C1-inhibitor and alpha2-plasmin inhibitor in arteriosclerotic diseases and diabetes mellitus (author's transl)]
Similar articles
-
[Relationship between antiplasmin capacity and concentration of alpha 2-plasmin inhibitor, alpha 2-macroglobulin, alpha 1-antitrypsin, antithrombin III or C1-inactivator in plasma of patients with transient ischemic attacks (author's transl)].Rinsho Byori. 1980 Mar;28(3):261-4. Rinsho Byori. 1980. PMID: 6154815 Japanese. No abstract available.
-
[The changes of natural clotting and fibrinolytic inhibitors in collagen and collagen like diseases (author's transl)].Rinsho Ketsueki. 1978 Jul;19(7):940-6. Rinsho Ketsueki. 1978. PMID: 81329 Japanese. No abstract available.
-
Changes in protease inhibitors after acute myocardial infarction.J Clin Pathol. 1976 Jul;29(7):639-41. doi: 10.1136/jcp.29.7.639. J Clin Pathol. 1976. PMID: 61974 Free PMC article.
-
Alpha 2-macroglobulin and antithrombin-heparin cofactor: modulators of hemostatic and inflammatory reactions. Alpha 2-macroglobulin.Prog Hemost Thromb. 1976;3:145-89. Prog Hemost Thromb. 1976. PMID: 59937 Review. No abstract available.
-
[Physiological anticoagulants. Current data on the composition, function and clinical value].Lab Delo. 1978;(10):579-87. Lab Delo. 1978. PMID: 81906 Review. Russian. No abstract available.